IP Verse

Long Lasting Effect Of New Botulinum Toxin Formulations - EP3079714

PATENT ANALYSIS

Patent Details

Grant Date
Nov 25, 2020
Company
MEDY-TOX, INC.
Oppositions

GALDERMA HOLDING SA

More patents of Medy-Tox, Inc.

EP3079714

Want to monitor this patent?

Feel free to send us a message here and we will get back to you